MedTrace Logo

Deep Brain Stimulation for Obsessive Compulsive Disorder (OCD PMCF)

NCT01135745 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2018-01-23

No results posted yet for this study

Summary

The purpose of the study is to monitor the safety and performance of Reclaim® Deep Brain Stimulation (DBS) Therapy in patients with chronic, severe, treatment-resistant Obsessive Compulsive Disorder.

Conditions

  • Obsessive Compulsive Disorder

Interventions

DEVICE

Reclaim® Deep Brain Stimulation

Implant of leads in pre-defined brain area; implant of neurostimulators

Sponsors & Collaborators

  • MedtronicNeuro

    lead INDUSTRY

Principal Investigators

  • Loes Gabriels, MD PhD MsEng · Professor of Psychiatry at UZ Leuven

  • Andreas Wahl-Kordon, MD · University Hospital Lübeck

  • Ludger Tebartz van Elst, MD · University Hospital Freiburg

  • Jose M Menchon, MD · University Hospital Bellvitge Barcelona

  • Antonio Higueras, MD · University Hospital Granada

  • Orsola Gambini, MD · University Hospital San Paolo Milan

  • Michael Schüpbach, MD · Insel Gruppe AG, University Hospital Bern

  • Siegried Kasper, MD · Department of Psychiatry and Psychotherapy Medical University of Vienna

  • Diana Radu-Djurfeldt · Karolinska Institutet, Stockholm

  • Renana Eitan · Hadassah-Hebrew University and Medical Center, Jerusalem

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • Belgium
  • Germany
  • Israel
  • Italy
  • Spain
  • Sweden
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01135745 on ClinicalTrials.gov